- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02690311
A Study on the Changes of the Biological Rhythm by Display Image Modulation
February 18, 2016 updated by: Samsung Medical Center
Effects of Smartphone Use at Night with Light Emitting Diode Display With and Without Blue Light in Healthy Adults: A Randomized, Double-blind, Cross-over, Placebo-controlled Comparison
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
(1) Healthy males 20-40 years of age who understood the study procedure and agreed to participate after being fully informed about the study were included.
Exclusion Criteria:
- psychiatric diseases according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria;15
- cognitive or neurological disorders;
- alcohol or substance abuse;
- unstable or serious medical illness;
- current use of psychoactive mediations including antidepressants, anxiolytics, neuroleptics, anticonvulsants, hypnotics, or stimulant medications;
- primary sleep disorder;
- habitual sleep onset earlier than 21:00 or later than 24:00;
- shift worker;
- travel across more than two time zones within 90 days of the study; and
- ophthalmologic disease during the study period.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: LED with bluelight
Two types of smartphone were used.
One type had a conventional LED display with the full range of blue light.
The LED in the other type newly developed by Samsung Display was suppressed for the blue light portion of the spectrum (wavelength 450 ~ 470 nm).
The smartphones were indistinguishable from each other with the naked eye, because other wavelengths mimicked blue light in the suppressed LED.
|
|
Experimental: LED without bluelight
Two types of smartphone were used.
One type had a conventional LED display with the full range of blue light.
The LED in the other type newly developed by Samsung Display was suppressed for the blue light portion of the spectrum (wavelength 450 ~ 470 nm).
The smartphones were indistinguishable from each other with the naked eye, because other wavelengths mimicked blue light in the suppressed LED.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes of serum melatonin
Time Frame: serum melatonin levels were measured every 60 min from 7:00 PM on day 1 to 8:00 AM on day 2, from 7:00 PM on day 2 to 8:00 AM on day 3, and from 7:00 PM to 11:00 PM on day 3 for 3 days.
|
serum melatonin levels were measured every 60 min from 7:00 PM on day 1 to 8:00 AM on day 2, from 7:00 PM on day 2 to 8:00 AM on day 3, and from 7:00 PM to 11:00 PM on day 3 for 3 days.
|
Changes of serum cortisol
Time Frame: cortisol levels were measured every 120 min from 7:00 PM on day 1 to 8:00 AM on day 2, from 7:00 PM on day 2 to 8:00 AM on day 3, and from 7:00 PM to 11:00 PM on day 3 for 3 days.
|
cortisol levels were measured every 120 min from 7:00 PM on day 1 to 8:00 AM on day 2, from 7:00 PM on day 2 to 8:00 AM on day 3, and from 7:00 PM to 11:00 PM on day 3 for 3 days.
|
Changes of body temperature
Time Frame: body temperature was measured every 120 min from 7:00 PM on day 1 to 8:00 AM on day 2, from 7:00 PM on day 2 to 8:00 AM on day 3, and from 7:00 PM to 11:00 PM on day 3 for 3days.
|
body temperature was measured every 120 min from 7:00 PM on day 1 to 8:00 AM on day 2, from 7:00 PM on day 2 to 8:00 AM on day 3, and from 7:00 PM to 11:00 PM on day 3 for 3days.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
profile of mood states(POMS)
Time Frame: day 1,3
|
Mood was measured using the POMS,17 a well-validated self-report measure of mood states.
|
day 1,3
|
Epworth Sleepiness Scale(ESS)
Time Frame: day 1,3
|
ESS18 is comprised of eight questions that query the subject's likelihood of dozing off or falling asleep in a particular situation that is commonly met in daily life.
|
day 1,3
|
Fatigue severity scale(FSS)
Time Frame: day 1,3
|
The FSS20 is composed of 9 statements (items) that describe fatigue symptoms.
Respondents select the most relevant level of agreement over the last week on a 7-point scale (1 strongly disagree; 7 strongly agree).
|
day 1,3
|
continuous performance test(CPT)
Time Frame: day1,3
|
Integrated visual-auditory CPTs were performed at days 1 and 3 by a psychologist who was an expert on cognitive tests
|
day1,3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
January 28, 2016
First Submitted That Met QC Criteria
February 18, 2016
First Posted (Estimate)
February 24, 2016
Study Record Updates
Last Update Posted (Estimate)
February 24, 2016
Last Update Submitted That Met QC Criteria
February 18, 2016
Last Verified
August 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 2013-08-072
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circadian Rhythm Phase Shift
-
Brigham and Women's HospitalActive, not recruitingSleep Disorders, Intrinsic | Sleep Disorders, Circadian Rhythm | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase Syndrome | Shift-Work Sleep Disorder | Delayed Sleep Phase | Non-24 Hour Sleep-Wake Disorder | Advanced Sleep Phase Syndrome | Advanced Sleep Phase | Irregular Sleep-Wake Syndrome | Shift...United States
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRecruitingSleep Disorders, Intrinsic | Sleep Wake Disorders | Sleep Disorders, Circadian Rhythm | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase Syndrome | Shift-Work Sleep Disorder | Delayed Sleep Phase | Non-24 Hour Sleep-Wake Disorder | Advanced Sleep Phase Syndrome | Advanced Sleep Phase | Irregular... and other conditionsUnited States
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityRecruitingShift Work Type Circadian Rhythm Sleep DisorderTaiwan
-
University of Massachusetts, WorcesterNot yet recruitingFatigue | Shift Work Type Circadian Rhythm Sleep DisorderUnited States
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
-
Columbia UniversityRecruitingEating Behavior | Shift Work Type Circadian Rhythm Sleep DisorderUnited States
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
-
Brigham and Women's HospitalStanford UniversityRecruitingSleep Wake Disorders | Sleep Disorder | Sleep Disorders, Circadian Rhythm | Circadian Rhythm Disorders | Circadian Rhythm Sleep Disorder | Advanced Sleep Phase Syndrome (ASPS) | Delayed Sleep Phase SyndromeUnited States
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brigham... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Insulin Resistance | Circadian Rhythm Sleep Disorder, Shift Work Type | Shift Work Type Circadian Rhythm Sleep DisorderUnited States
-
Oregon State UniversityMonash University; Stanford University; American Academy of Sleep MedicineRecruitingSleep Initiation and Maintenance Disorders | Circadian Rhythm Sleep-Wake Disorders, Shift Work TypeUnited States
Clinical Trials on smartphone display
-
Universitätsklinikum KölnCompleted
-
Jamieson Bourque, MDAdvanced Medical Predictive Devices, Diagnostics and Displays, Inc.Active, not recruitingClinical DeteriorationUnited States
-
MidAtlantic RetinaAlcon ResearchCompletedComparison of 3D Visualization and Microscope for VR SurgeryUnited States
-
Centre Hospitalier Universitaire VaudoisUniversity of LausanneCompletedPost Traumatic Stress Disorder | Childbirth ExperienceSwitzerland
-
Poitiers University HospitalCompletedRehabilitation | Knee Surgery | Point Light DisplayFrance
-
National Institute on Drug Abuse (NIDA)CompletedPain | Chronic Pain
-
Microsoft ResearchSchneider Children's Medical Center, Israel; Interdisciplinary Center HerzliyaCompletedSmoking Cessation | Obesity | AnorexiaIsrael
-
RealView ImagingEnrolling by invitationThree-dimensional (3D) Holographic Display for Ultrasound-Guided Structural Heart Disease ProceduresStructural Cardiac DefectsUnited States
-
University of MichiganAgency for Healthcare Research and Quality (AHRQ)CompletedCatheter-Related Infections | Pressure InjuryUnited States
-
Indonesia UniversityCompletedDifficult Vein AccessIndonesia